Quattrone, Diego; Reininghaus, Ulrich; Richards, Alex L.; Tripoli, Giada; Ferraro, Laura; Quattrone, Andrea; Marino, Paolo; Rodriguez, Victoria; Spinazzola, Edoardo; Gayer-Anderson, Charlotte; Jongsma, Hannah E.; Jones, Peter B.; Cascia, Caterina La; La Barbera, Daniele; Tarricone, Ilaria; Bonora, Elena; Tosato, Sarah; Lasalvia, Antonio; Szoke, Andrei; Arango, Celso; Bernardo, Miquel; Bobes, Julio; Del-Ben, Cristina Marta 
; Menezes, Paulo Rossi ; Llorca, Pierre-Michel; Santos, José Luís dos; Sanjuan, Julio; Arrojo, Manuel; Tortelli, Andrea; Velthorst, Eva; Berendsen, Steven; Haan, Lieuwe de; Rutten, Bart P. F.; Lynskey, Michael; Freeman, Tom P.; Kirkbride, James B.; Sham, Pak; O’Donovan, Michael; Cardno, Alastair G.; Vassos, Evangelos; van Os, Jim; Morgan, Craig; Murray, Robin M.; Lewis, Cathryn M.; Forti, Marta Di; Loureiro, Camila Marcelino; Shuhama, Rosana
Source: Translational Psychiatry. Unidades: FMRP, FM, EERP
Subjects: CANNABIS, REGRESSÃO LINEAR, TRANSTORNOS PSICÓTICOS, FATORES DE RISCO, ESQUIZOFRENIA
ABNT
QUATTRONE, Diego et al. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Translational Psychiatry, v. 11, n. 1, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41398-021-01526-0. Acesso em: 28 jun. 2024.APA
Quattrone, D., Reininghaus, U., Richards, A. L., Tripoli, G., Ferraro, L., Quattrone, A., et al. (2021). The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Translational Psychiatry, 11( 1). doi:10.1038/s41398-021-01526-0NLM
Quattrone D, Reininghaus U, Richards AL, Tripoli G, Ferraro L, Quattrone A, Marino P, Rodriguez V, Spinazzola E, Gayer-Anderson C, Jongsma HE, Jones PB, Cascia CL, La Barbera D, Tarricone I, Bonora E, Tosato S, Lasalvia A, Szoke A, Arango C, Bernardo M, Bobes J, Del-Ben CM, Menezes PR, Llorca P-M, Santos JL dos, Sanjuan J, Arrojo M, Tortelli A, Velthorst E, Berendsen S, Haan L de, Rutten BPF, Lynskey M, Freeman TP, Kirkbride JB, Sham P, O’Donovan M, Cardno AG, Vassos E, van Os J, Morgan C, Murray RM, Lewis CM, Forti MD, Loureiro CM, Shuhama R. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study [Internet]. Translational Psychiatry. 2021 ; 11( 1):[citado 2024 jun. 28 ] Available from: https://doi.org/10.1038/s41398-021-01526-0Vancouver
Quattrone D, Reininghaus U, Richards AL, Tripoli G, Ferraro L, Quattrone A, Marino P, Rodriguez V, Spinazzola E, Gayer-Anderson C, Jongsma HE, Jones PB, Cascia CL, La Barbera D, Tarricone I, Bonora E, Tosato S, Lasalvia A, Szoke A, Arango C, Bernardo M, Bobes J, Del-Ben CM, Menezes PR, Llorca P-M, Santos JL dos, Sanjuan J, Arrojo M, Tortelli A, Velthorst E, Berendsen S, Haan L de, Rutten BPF, Lynskey M, Freeman TP, Kirkbride JB, Sham P, O’Donovan M, Cardno AG, Vassos E, van Os J, Morgan C, Murray RM, Lewis CM, Forti MD, Loureiro CM, Shuhama R. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study [Internet]. Translational Psychiatry. 2021 ; 11( 1):[citado 2024 jun. 28 ] Available from: https://doi.org/10.1038/s41398-021-01526-0
